Cisplatin

14 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
aprepitant	Mylan II B.V. (MYL)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
granisetron	Amneal Pharmaceuticals, Inc. (AMRX)
granisetron	Sana Biotechnology, Inc. (SANA)
pedmark	FENNEC PHARMACEUTICALS INC. (FENC)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
portrazza	ELI LILLY & Co (LLY)

Phase 3(3)

Drug	Company
avasopasem manganese	Galera Therapeutics, Inc. (GRTX)
Procedure/Standard care	Merus N.V. (MRUS)
Vortioxetine tablets	Merus N.V. (MRUS)

Phase 1(1)

Drug	Company
db-020	Decibel Therapeutics, Inc. (DBTX)

Preclinical(1)

Drug	Company
oto-510	OTONOMY, INC. (OTIC)

N/A(1)

Drug	Company
Pentoxifylline 400 mg SR tablets	Merus N.V. (MRUS)

BioSniper tracks 14 drugs in development for Cisplatin across 11 companies.

There are 1 clinical trial targeting Cisplatin tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.